Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bioasis Technologies Inc. > recent press and videos
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(559)
•••
Post by chrispion Jul 09, 2021 12:57pm
145 Views
Post# 33521704

recent press and videos

recent press and videosTwo new videos about Bioasis were released this week from https://equity.guru/ :
 
1.     Jody Vance interview with Deborah Rathjen (Executive Chair, Bioasis)
https://www.youtube.com/watch?v=w7Lmh3hc9Pw
 
2.     2 min 56 sec Company Overview
https://www.youtube.com/watch?v=w1XXYEr9a4s
 
In addition to the three recent articles from them:
https://equity.guru/2021/07/07/bioasis-technologies-bti-v-announces-positive-results-from-xb3-il-1ra-study/
 
https://equity.guru/2021/07/06/bioasis-technologies-bti-v-stock-is-on-the-move-following-scientific-validation-of-xb3-platform/
 
https://equity.guru/2021/07/02/bioasis-bti-v-begins-research-collaboration-oxyrane-uk-appoints-new-cfo/
 
and their original introduction article https://equity.guru/2021/06/03/bioasis-technologies-bti-v-biopharma-dark-horse-in-the-making/
 
And this article https://themarketherald.ca/bioasis-announces-positive-results-from-an-efficacy-study-of-xb3tm-il-1ra-in-a-model-of-multiple-sclerosis-2021-07-07/ , although not giving additional scientific data, does an excellent job of summarizing the il-1ra study press release in an easy-to-understand way for non-biotech people.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities